Machine-learning prediction of cancer survival: a retrospective study using electronic administrative records and a cancer registry. Issue 3 (17th March 2014)

• Record Type: Journal Article
• Authors: Gupta, Sunil; Tran, Truyen; Luo, Wei; Phung, Dinh; Kennedy, Richard Lee; Broad, Adam; Campbell, David; Kipp, David; Singh, Madhu; Khasraw, Mustafa; Matheson, Leigh; Ashley, David M; Venkatesh, Svetha
• Is Part Of: BMJ open. Volume 4:Issue 3(2014)
• Publication Date: 2014-03-17
• Subjects: Cancer -- Survival -- Prediction -- Machine Learning -- Electronic Medical Record; Medicine -- Research -- Periodicals; 610.72
• DOI: 10.1136/bmjopen-2013-004007
• Languages: English
• ISSNs: 2044-6055

Abstract

Abstract : Objectives: Using the prediction of cancer outcome as a model, we have tested the hypothesis that through analysing routinely collected digital data contained in an electronic administrative record (EAR), using machine-learning techniques, we could enhance conventional methods in predicting clinical outcomes. Setting: A regional cancer centre in Australia. Participants: Disease-specific data from a purpose-built cancer registry (Evaluation of Cancer Outcomes (ECO)) from 869 patients were used to predict survival at 6, 12 and 24 months. The model was validated with data from a further 94 patients, and results compared to the assessment of five specialist oncologists. Machine-learning prediction using ECO data was compared with that using EAR and a model combining ECO and EAR data. Primary and secondary outcome measures: Survival prediction accuracy in terms of the area under the receiver operating characteristic curve (AUC). Results: The ECO model yielded AUCs of 0.87 (95% CI 0.848 to 0.890) at 6 months, 0.796 (95% CI 0.774 to 0.823) at 12 months and 0.764 (95% CI 0.737 to 0.789) at 24 months. Each was slightly better than the performance of the clinician panel. The model performed consistently across a range of cancers, including rare cancers. Combining ECO and EAR data yielded better prediction than the ECO-based model (AUCs ranging from 0.757 to 0.997 for 6 months, AUCs from 0.689 to 0.988 for 12 months and AUCs from 0.713 to 0.973 for 24 months). The best prediction was for genitourinary, head and neck, lung, skin, and upper gastrointestinal tumours. Conclusions: Machine learning applied to information from a disease-specific (cancer) database and the EAR can be used to predict clinical outcomes. Importantly, the approach described made use of digital data that is already routinely collected but underexploited by clinical health systems.